Marrow-derived MSCs and atorvastatin improve cardiac function in rat model of AMI
- 1 July 2011
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 150 (1) , 28-32
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarctionClinical Science, 2008
- In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cellsBiochemical and Biophysical Research Communications, 2006
- The Effects of HMG-CoA Reductase Inhibitor on Vascular Progenitor CellsJournal of Pharmacological Sciences, 2006
- Hypoxia and Serum Deprivation-Induced Apoptosis in Mesenchymal Stem CellsStem Cells, 2005
- Atorvastatin Induction of VEGF and BDNF Promotes Brain Plasticity after Stroke in MiceJournal of Cerebral Blood Flow & Metabolism, 2005
- Systemic Delivery of Bone Marrow–Derived Mesenchymal Stem Cells to the Infarcted MyocardiumCirculation, 2003
- RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrowNature, 2002
- Bone marrow cells regenerate infarcted myocardiumNature, 2001
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999
- Chronic Heart Failure in the United StatesCirculation, 1998